Department of Surgery, University of California San Diego, San Diego, CA 92093, USA.
Department of Surgical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.
Cells. 2022 Jan 12;11(2):249. doi: 10.3390/cells11020249.
Colorectal cancer (CRC) is a common cause of cancer and cancer-related death. Surgery is the only curative modality. Fluorescence-enhanced visualization of CRC with targeted fluorescent probes that can delineate boundaries and target tumor-specific biomarkers can increase rates of curative resection. Approaches to enhancing visualization of the tumor-to-normal tissue interface are active areas of investigation. Nonspecific dyes are the most-used approach, but tumor-specific targeting agents are progressing in clinical trials. The present narrative review describes the principles of fluorescence targeting of CRC for diagnosis and fluorescence-guided surgery with molecular biomarkers for preclinical or clinical evaluation.
结直肠癌(CRC)是癌症和癌症相关死亡的常见原因。手术是唯一的治愈方式。使用靶向荧光探针增强 CRC 的荧光可视化,可以描绘边界并靶向肿瘤特异性生物标志物,从而提高治愈性切除的比率。增强肿瘤-正常组织界面可视化的方法是目前研究的活跃领域。非特异性染料是最常用的方法,但肿瘤特异性靶向剂在临床试验中正在取得进展。本叙述性综述描述了使用分子生物标志物进行 CRC 的荧光诊断和荧光引导手术的荧光靶向原理,用于临床前或临床评估。